EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Haleon's Enterprise Value is $48,377 Mil.
Haleon's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $2,681 Mil. Therefore, Haleon's EV-to-EBIT for today is 18.04.
The historical rank and industry rank for Haleon's EV-to-EBIT or its related term are showing as below:
HLN'
s EV-to-EBIT Range Over the Past 10 Years
Min: 12.21 Med: 16.44 Max: 24.1
Current: 18.03
During the past 5 years, the highest EV-to-EBIT of Haleon was 24.10. The lowest was 12.21. And the median was 16.44.
HLN's EV-to-EBIT is ranked worse than 50.67% of 669
companies
in the Drug Manufacturers industry
Industry Median: 17.95
vs HLN: 18.03
The historical data trend for Haleon's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haleon's EV-to-EBIT Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haleon's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Haleon's EV-to-EBIT falls into.
Haleon's current Enterprise Value is $48,377 Mil.
Haleon's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,681 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haleon (NYSE:HLN) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Haleon's Enterprise Value for the quarter that ended in Mar. 2024 was $38,767 Mil.
Haleon's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,681 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haleon EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Haleon's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HLN has been successfully added to your 